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Background: Lyme disease is the most prevalent tick-borne disease in the USA with the highest number of
cases (27444 patients) reported by CDC in the year 2007, representing an unprecedented 37% increase from
the previous year. The haematogenous spread of Borrelia burgdorferi to various tissues results in
multisystemic disease affecting the heart, joints, skin, musculoskeletal and nervous system of the patients.
Objectives: Although Lyme disease can be effectively treated with doxycycline, amoxicillin and cefuroxime
axetil, discovery of novel drugs will benefit the patients intolerant to these drugs and potentially those
suffering from chronic Lyme disease that is refractory to these agents and to macrolides. In this study, we
have explored 50-methylthioadenosine/S-adenosylhomocysteine nucleosidase as a drug target for B.
burgdorferi, which uniquely possesses three genes expressing homologous enzymes with two of these
proteins apparently exported.
Methods: The recombinant B. burgdorferi Bgp and Pfs proteins were first used for the kinetic analysis of
enzymatic activity with both substrates and with four inhibitors. We then determined the antispirochaetal
activity of these compounds using a novel technique. The method involved detection of the live–dead B.
burgdorferi by fluorometric analysis after staining with a fluorescent nucleic acids stain mixture containing
Hoechst 33342 and Sytox Green.
Results: Our results indicate that this method can be used for high-throughput screening of novel
antimicrobials against bacteria. The inhibitors formycin A and 5’-ρ-nitrophenythioadenosine particularly
affected B. burgdorferi adversely on prolonged treatment.
Conclusions: On the basis of our analysis, we expect that structure-based modification of the inhibitors can
be employed to develop highly effective novel antibiotics against Lyme spirochaetes.
Keywords: Lyme disease, enzyme inhibitors, Bgp, fluorometric assay, spirochete
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Introduction
Lyme disease, caused by the spirochaete Borrelia burgdorferi, is the most prevalent tick-borne multisystemic illness and
affects the heart, joints, skin, musculoskeletal and nervous system. Persistent infection with the spirochaete results in
potentially incapacitating arthritis, neuroborreliosis, acrodermatitis chronicum atrophicans and carditis. Doxycycline,
amoxicillin or cefuroxime axetil are recommended as the first-line therapy for early and late Lyme disease. Macrolides are
less effective against B. burgdorferi,1,2 and resistance of these spirochaetes to erythromycin has been reported.3 As a result,
macrolides, including azithromycin, clarithromycin and erythromycin, are recommended only for patients intolerant to the
first-line therapy. Hence, discovery of new antimicrobials that could be used alone or in combination with other antibiotics
will be highly beneficial for drug-intolerant patients and potentially for patients suffering from chronic Lyme disease that is
refractory to other agents.
One potential drug target that has been identified is the enzyme 5’-methylthioadenosine/S-adenosyl-homocysteine
(MTA/SAH) nucleosidase,4 an enzyme present in most bacterial species but absent in humans. MTA/SAH nucleosidase
cleaves the glycosidic linkage of the nucleosides to generate the thiosugars 5-methylthioribose (MTR) or Sribosylhomocysteine (SRH) and the purine adenine.5 In bacteria, MTA is produced from S-adenosylmethionine (SAM) as a
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by-product of polyamine and autoinducer I synthesis, while SAH is derived from SAM-mediated methylation reactions.
MTR and SRH can be salvaged through separate routes to methionine, while adenine re-enters the purine pools of the cell.
Cleavage of SRH by the enzyme LuxS yields homocysteine, which can be remethylated to methionine, and 4,5-dihydroxy2,3-pentanedione (DPD), a precursor for autoinducer-2 (AI-2) synthesis. Thus, the activity of the nucleosidase is connected to
the production of two bacterial quorum-sensing autoinducers.6–8 These autoinducers are involved in the induction of various
virulence factors in bacteria and contribute to their pathogenesis.6–8
Nucleosidase inhibitors could exert antimicrobial actions by one or more mechanisms and have been explored as a target for
the design of the broad-spectrum antibiotics against Gram-positive and Gram-negative bacteria by several laboratories.4,9 – 15
MTA and SAH are known to inhibit polyamine synthase16,17 and methyltransferase18 activities in various organisms. Thus,
inhibition of the nucleosidase could work by promoting a build-up of MTA and SAH to growth-inhibitory levels. In addition,
the loss of salvage of purine and methionine components may suppress bacterial growth by nutrient limitation, and because it
is energetically expensive to make methionine de novo.
Due to the absence of major biosynthetic pathways, it is particularly important for the nutritional auxotroph, B. burgdorferi,
to recycle metabolic by-products. However, Borrelia species lack methionine synthase (metH), which is required to
remethylate homocysteine to methionine, and do not have a functional mtnK gene (methylthioribose kinase) required to
salvage methionine from MTR.19 Loss of adenine salvage by nucleosidase inhibition may have a significant effect on B.
burgdorferi, since they are purine auxotrophs. Alternatively, interruption of the synthesis of SRH and DPD, and subsequent
loss of AI-2 signaling may represent a unique aspect of nucleosidase inhibitors7,20 as Lyme spirochaetes are known to
synthesize AI-2 and alter surface protein expression in response to this autoinducer.21,22
Previously, we identified a glycosaminoglycan-binding protein located on the surface of B. burgdorferi and named it Borrelia
glycosaminoglycan-binding protein or Bgp.23 Interestingly, Bgp is homologous to the cytoplasmic Pfs protein present in a
wide variety of bacterial species and also exhibits MTA/SAH nucleosidase activity.24 The genome sequence of B. burgdorferi
shows the presence of three Pfs homologues: Pfs (BB0375), Bgp (BB0588) and MtnN (BBI06).25 The translated sequences
for bgp and plasmid-borne mtnN genes contain predictable signal peptides, indicating that they are potentially exported
proteins.23 Indeed, we have shown that Bgp is a surface protein and its sequence analysis showed that the mature Bgp protein
lacks the signal peptide.23 Synthesis of MtnN and its cellular localization and enzymatic activity have not yet been
determined. The cytoplasmic Pfs in the Lyme spirochaetes also exhibits MTA/SAH nucleosidase activity24 and is a part of the
four-gene (BB0374-pfs-metK-luxS) operon encoding proteins involved in the synthesis of the quorum-sensing molecule, AI2. Lyme spirochaetes are the only known bacteria in which more than one copy of nucleosidase genes are present, with two
gene products apparently exported.25 The B. burgdorferi genome is rather small (1.52 Mb), and is approximately one-third of
the size of the Escherichia coli genome (4.6 Mb). The presence of multiple MTA/SAH nucleosidases suggests that the
enzymes are important for Lyme disease spirochaetes. Since B. burgdorferi lacks a majority of the biosynthetic pathways,
MTA/SAH nucleosidases could play a critical role in the salvage of the purine adenine from MTA and SAH that is derived
from both pathogen and host metabolisms. B. burgdorferi is likely to recycle this macromolecule building block more
efficiently due to the presence of MTA/SAH nucleosidase enzymes both in the cytoplasm and on the spirochaete surface.
Therefore, this enzyme offers us a unique opportunity to explore substrate analogues as antimicrobials against this important
human pathogen.
The slow growth and unreliable colony formation ability of B. burgdorferi on solid media makes traditional plating methods
unsuitable to screen and assess the effect of antimicrobials on spirochaete viability. Therefore, we have developed here a
fluorescence-based high-throughput screening system involving a combination of Hoechst 33342 and Sytox Green nucleic
acid stains to distinguish total and dead spirochaetes, respectively. Sytox Green is excluded by the plasma membrane of live
organisms, and hence it stains nucleic acids of only the dead or physiologically compromised microbes.26,27 A direct
correlation was observed between Sytox Green staining and the proportion of dead spirochaetes in the sample. After
comparing the activities of four MTA/SAH nucleosidase inhibitors on recombinant B. burgdorferi Bgp and Pfs proteins, we
determined the effects of these compounds on spirochaete growth by employing this nucleic acid stain combination. Lastly,
structure-based modeling was used to visualize potential interactions of MTA analogues with B. burgdorferi nucleosidases
and to predict modifications that may lead to more selective and potent antiborrelial agents.
Materials and methods
Bacterial strains and culture.
B. burgdorferi isolate B314, a high-passage, non-infectious derivative of the infectious B31 strain, which has lost all
endogenous plasmids except cp26 and cp32, and an infectious strain N40 clone D10/E9 were used in this study. Since the
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lp28-4 plasmid possessing the mtnN gene is missing in B314, this isolate can only express Pfs and Bgp while the infectious
N40 strain can possibly express all three genes, pfs, bgp and mtnN. The spirochaetes were grown at 33°C in BSK II medium
containing 6% rabbit serum to a density of 108 spirochaetes/mL for each assay. To study the effect of inhibitors and
ampicillin on the growth of B. burgdorferi, cultures were grown in a 5% CO2 incubator at 37°C.
Assessment of the fluorescence-based system in high-throughput screening of live–dead B. burgdorferi.
B. burgdorferi cultures were grown to a density of ~108 spirochaetes/mL and divided into two aliquots. One aliquot was
incubated at 60°C for 30 min to kill the spirochaetes. A 10-fold serial dilution of dead B. burgdorferi was prepared in
remaining live bacterial suspension such that the ratio of live spirochaetes decreased from 100% to 0% and dead spirochaetes
increased from 0% to 100% (i.e. 100:0 to a final 0:100 ratio of live–dead B. burgdorferi). Two hundred microlitres of culture
mixture was transferred to each well of a 96-well black plate with a clear bottom (Catalog number 3603, Corning
Incorporated, NY, USA). Two microlitres of a 1:1 mixture of 5 µM Sytox Green and 10 µM Hoechst 33342 was added to
each well. After mixing, the plate was incubated at 37°C for 1–2 h and the Sytox Green (excitation 504nm /emission 523 nm)
and Hoechst 33342 (excitation 350 nm/emission 461 nm) fluorescences were measured using a Spectramax M2
spectrophotometer/microplate reader (Molecular Devices, CA, USA). The ratio of the fluorescence emission due to Sytox
Green binding to nucleic acids determined the presence of dead spirochaetes and staining with Hoechst, which estimated both
live and dead B. burgdorferi in the sample, provided the net fluorescence due to the dead spirochaetes. The standard curve
between the known percentage of dead spirochaetes and net Sytox Green fluorescence for B314 and N40 strains was
prepared to determine the sensitivity of detection of dead non-infectious versus infectious B. burgdorferi strains. Six
replicates were used for each treatment and each experiment was repeated at least three times to confirm the reproducibility
of the assay.
For fluorescence microscopy, the spirochaetes were centrifuged after incubation with the stain mixture, washed once with
PBS and mounted in a 1:1 PBS/glycerol mixture. Sealing with nail polish limited the evaporation and prevented movement of
the cover glasses. Differential interference contrast (DIC) provision in the Nikon 80i fluorescence microscope was used to
observe total spirochaetes present in any field of view. DAPI (for Hoechst 33342 staining) and FITC (for Sytox Green
staining) filters were used with x100 magnification Apo-Plan TIRF objective to examine whether total spirochaetes observed
by DIC are also visualized by Hoechst staining and whether physiologically compromised spirochaetes are detectable by
Sytox Green staining.
Effect of ampicillin on B. burgdorferi growth.
Lyme disease is treated with penicillin, tetracycline and cephalosporin classes of antibiotics.1,2 Therefore, the efficacy of the
fluorescence-based assay system was first assessed using ampicillin treatment of B. burgdorferi. Ten 2-fold dilutions of
ampicillin were prepared starting from 200 mg/mL. Ten microlitres of each antibiotic dilution was added to 190 µL of B.
burgdorferi culture in each of the six replicate wells of the 96-well black plate to obtain final concentrations of ampicillin
from 10 to 0.0195 µg/well. After mixing for 5 min, the plate was incubated overnight at 37°C with 5% CO2. The Sytox Green
and Hoechst 33342 mixture was then added to each well, mixed, incubated for 1–2 h at 37°C and the fluorescence measured
as described earlier. A standard prepared with known live–dead B. burgdorferi mixtures was used to calculate the percentage
of dead/killed spirochaetes present in each treated sample.
Examination of substrate and inhibitor activity for B. burgdorferi MTA/SAH nucleosidases, Bgp and cytoplasmic Pfs.
Unlike other bacteria, B. burgdorferi contains cytoplasmic (Pfs) and homologous cell surface proteins (Bgp and probably also
MtnN), with at least Bgp and Pfs showing MTA/SAH nucleosidase activity.24 For the present study, recombinant His-tagged
Bgp and Pfs were expressed and purified as previously described.24 The concentrations of recombinant Bgp and Pfs were
determined using a Cary 100 scanning UV/Visible spectrophotometer (Varian, Palo Alto, CA, USA), and absorbance 280
(0.1%) values of 0.705 (Bgp) and 0.487 (Pfs). Enzyme activity was studied using a UV assay that follows the drop in
absorbance at 275 nm that accompanies the conversion of the nucleoside into adenine and the corresponding thiosugar.28,29
Specific activity measurements employed reaction mixtures containing 100 µM nucleoside and 100 mM sodium phosphate
buffer at the optimized pH for each enzyme (pH 7 for Bgp; pH 5 for Pfs). Substrate nucleosides (MTA and SAH) and the
inhibitor formycin A (FMA) were obtained from Sigma (St Louis, MO, USA). The inhibitors 5’-ρ-nitrophenyl-thioadenosine
(pNO2PhTA) and 5’-ρ-aminophenylthioadenosine (pNH2PhTA) were gifts from Drs M. K. Riscoe and R. W. Winter
(Veterans Affairs Medical Center, Portland, OR, USA). The transition-state analogue, BnT-DADMe-ImmA, was a gift from
Drs Y. S. Babu and J. Zhang (BioCryst Pharmaceuticals, Birmingham, AL, USA). Conversion of substrate into adenine was
calculated using an extinction coefficient (275 nm) for nucleoside decay of 1.6 mM-1cm-1. Concentrations of nucleosides
were estimated by UV absorbance at 260 nm and an extinction coefficient of 15400 M-1cm-1. Reactions were initiated by the
addition of 1–2 µg of enzyme and followed for 20–30 min at 22°C. For the determination of kinetic constants, substrates
(MTA or SAH) were tested from 1 to 100 µM, with at least triplicate measurements performed at each concentration.
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Kinetics data were fitted to the Michaelis–Menten equation using Igor Pro 5.0 (Wavemetrics, Lake Oswego, OR, USA).
Enzyme inhibition was analysed using the UV assay, with varying concentrations of the inhibitor (10–500 nM for BnTDADMe-ImmA; 1–10 µM for pNO2PhTA and pNH2PhTA; and 25–250 µM for FMA) incorporated into reactions containing
100 µM MTA.29 Controls having either no enzyme or no inhibitor were included in all experiments. The inhibition constant
(Ki) was obtained by fitting the initial rate and inhibitor concentration to an equation for competitive inhibition:

where Vo’ and Vo are the initial rates of the inhibited and uninhibited reactions, respectively, [I] the inhibitor concentration
and [S] the concentration of MTA.29
Assessment of the selected inhibitors of MTA/SAH nucleosidase as antimicrobials against B. burgdorferi.
Four MTA/SAH nucleosidase inhibitors, FMA, pNO2PhTA, pNH2PhTA and BnT-DADMe-ImmA, were selected on the
basis of the results of an in vitro assay with purified B. burgdorferi Bgp and Pfs proteins. Fivefold serial dilutions of each of
the inhibitors were prepared from 200 to 0.32 µM (final concentrations of 10–0.016 µM). Four replicates of each treatment
were used. The experiment was conducted as described earlier for ampicillin, and fluorometric and microscopic observations
taken. To distinguish the bacteriostatic versus bactericidal activities of the inhibitors, the plate was incubated for 7 days. An
aliquot of 2 µL of culture from each well was transferred to 1 mL of BSK II medium containing rabbit serum, to allow viable
spirochaetes in the sample to recover and grow. After 14–21 days of incubation of culture tubes without inhibitors at 33°C,
the presence of viable, motile spirochaetes was recorded using a dark-field microscope.
Modeling studies.
High homology between B. burgdorferi MTA/SAH nucleosidase sequences and the corresponding E. coli enzyme (which has
several solved crystal structures) and complete conservation of active site residues involved in catalysis were used in
preliminary modeling studies to generate three-dimensional structures for Bgp and Pfs that might be instructive for future
drug design. Initial models were created using the structural coordinates for E. coli nucleosidase containing bound FMA
(PDB accession no. 1NC3A). Sequence threading was accomplished using the program SWISS-Model and sequence overlays
were further refined using ViewerPro 4.2 (Accelerys).30 – 32
Results
Sensitivity of detection of dead or dying B. burgdorferi by Sytox Green stain.
Spirochaetes killed by heating at 60°C for 30 min were used to generate a standard curve between relative fluorescence
(Sytox/Hoechst) and known percentage of dead/physiologically compromised B. burgdorferi cells. In this assay, the green
fluorescence of B. burgdorferi isolate B314 (Figure 1a) showed a high co-efficient of correlation (r2=0.962) with dead
bacteria, indicating that staining of the nucleic acids by Sytox Green only occurs when viability of the spirochaetes is
affected. Sensitivity of detection using Sytox Green stain was 10% dead spirochaetes since the assay could detect this level of
system. killed B. burgdorferi reproducibly. The fluorescence values obtained using Hoechst 33342 DNA stain among
different treatments within an experiment showed a standard deviation of <4% (data not shown). These results indicate that
the total proportion of bacteria (live plus dead) in each sample, as detected by Hoechst staining, was accurately determined
among different treatments, offering it to be a valuable control to assess consistency in spirochaete number in this assay
system.
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Figure 1. Sytox Green staining of both dead non-infectious B. burgdorferi isolate B314 and infectious B.
burgdorferi strain N40 clone D10/E9 can be used to determine the IC50 of ampicillin by fluorometric
analysis equally effectively. (a and c) Different dilutions of heat-killed (608C for 30 min) B314 and N40
spirochaetes in the samples were examined after staining with Hoechst 33342/Sytox Green fluorescent DNA
staining dyes. Quantification of Sytox Green (excitation 504 nm/emission 523 nm) fluorescence was
normalized with the fluorescence obtained by Hoechst staining (excitation 350 nm/emission 461 nm) after
measuring the fluorescence using a Spectramax M2 spectrophotometer reader. A standard curve prepared
between net Sytox Green fluorescence and known dead spirochaetes showed a high coefficient of
correlation (r2=0.962 and 0.978 for B314 and N40, respectively). (b and d) The standard curve was used to
determine the percentage killing of the B314 isolate after treatment with different concentrations of
ampicillin overnight. The IC50 for the N40 strain (d) was the same (1.75 mg/mL) as that for the noninfectious isolate B314 (c).

IC50 determination of ampicillin against B. burgdorferi using fluorescence-based assay system.
Non-infectious B. burgdorferi isolate B314 was treated with 2-fold serial dilutions of ampicillin starting with 10 mg/200 mL
of culture per well for 24 h. Determination of net Sytox Green fluorescence by fluorometric analysis indicated that similar to
the heat-killed bacteria, B. burgdorferi were also unable to exclude this nucleic acid stain after treatment with ampicillin
(Figure 1b). The IC50 of ampicillin calculated from the graphs (Figure 1a and b) was 0.35 µg per well or 1.75 µg/mL of B314
culture.
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A similar analysis of the B. burgdorferi N40 strain (Figure 1c) showed that Sytox Green stain could distinguish dead and
infectious spirochaetes as well. Again, a high coefficient of correlation (r2=0.978) was observed between the known
percentage of dead N40 spirochaetes present in a sample and net Sytox Green fluorescence values (Figure 1c). Furthermore,
IC50 for ampicillin against N40 strain is equivalent to that for the B314 isolate, i.e. 1.75 µg/mL of culture (Figure 1b–d),
indicating that this stain can detect dead noninfectious and infectious Lyme spirochaetes indistinguishably. Therefore, only
the infectious N40 strain clone D10/E9 was used for all further experiments.
For further validation of our assay, we examined the spirochaetes using fluorescence microscopy. As predicted, all
spirochaetes present in a field of view were visible by both DIC microscopy as well as by Hoechst staining (Figure 2).
However, only spirochaetes treated with heat (60°C) showed bright green fluorescence using the FITC filter due to the
nucleic acids staining with Sytox Green. Bleaching of the stains was very quick for B. burgdorferi treated with ampicillin,
probably due to the beginning of DNA degradation, and was not suitable for photomicroscopy (data not shown).

Figure 2. Microscopic examination of live and heat-killed B. burgdorferi strain N40 clone D10/E9 after
Hoechst/Sytox Green double staining. The samples were centrifuged after incubation with the nucleic
acid dyes, washed once with PBS and mounted in 1:1 PBS/glycerol mixture. The cover glasses were
sealed with nail polish to limit evaporation. DIC provision in the Nikon 80i fluorescence microscope
was used to observe total spirochaetes present in any field of view. DAPI (for Hoechst 33342 staining)
and FITC (for Sytox Green) filters were used. Total spirochaetes were observed by Hoechst staining and
physiologically compromised spirochaetes by Sytox Green staining by using an Apo-Plan TIRF x100
magnification objective. This figure appears in colour in the online version of JAC and in black and
white in the print version of JAC.
Kinetic analysis of MTA/SAH nucleosidase substrate analogues with purified recombinant Bgp and Pfs proteins. Specific
activity measurements performed at saturating levels of MTA or SAH confirmed that both Bgp and Pfs are dual-substratespecific enzymes. Freshly prepared Bgp and Pfs exhibited specific activities for MTA of 4.1 and 4.4 U/mg enzyme and for
SAH 3.1 and 3.7 U/mg, respectively (Table 1), indicating that each of the preparations contained similar levels of active
enzyme. The nucleoside analogue, pNH2PhTA, was a very poor substrate for Bgp (0.2 U/mg) and Pfs (0.024 U/mg), with no
substrate activity detected at concentrations <50 µM (data not shown). The analogue pNO2PhTA was a slightly better
substrate for Pfs (2.0 U/mg) than for Bgp (0.83 U/mg), but here as well, detectible substrate activity <20 µM was unreliable.
As expected, FMA and BnT-DADMe-ImmA were not cleaved due to the absence of a hydrolysable glycosidic linkage. A
summary of the results of kinetic analysis of substrate and inhibitor activities is found in Figure 3. For the two enzymes, only
the differences in activity against MTA and FMA were statistically significant (P<0.01; Student’s t-test). The differences in
activity between the two enzymes towards SAH, pNO2PhTA, pNH2PhTA and BnT-DADMe-ImmA were not significant
(P>0.05), suggesting that each enzyme recognizes bulkier 5’ substitutions in compounds to similar levels. Of the inhibitors
tested, BnT-DADMe-ImmA (Ki=2.3–3.4 nM) showed the tightest binding to the nucleosidases with Ki values roughly two to
three orders of magnitude smaller than the Michaelis constant (Km) values reported for MTA (Km=0.7–5 µM) and SAH
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(Km=1.2–1.6 µM). This result is expected, since BnT-DADMe-ImmA is a transition-state analogue, and belongs to a class of
compounds that have previously been reported to show picomolar and femtomolar dissociation constants for the E. coli
nucleosidase.29

Table 1. Summary of specific activity measurements for Bgp and Pfs

Enzyme activities were tested using the UV spectrophotometric assay (275
nm) and either 100 µM substrate (MTA and SAH) or 100 µM substrate
analogue (pNH2PhTA, pNO2PhTA, FMA and BnT-DADMe-ImmA).
With the exception of FMA, where the Ki (1.05 and 2.69 µM) was less than the 10 µM reported for the E. coli enzyme,10 the
inhibitors generally showed somewhat less activity towards the spirochaetal enzymes. For the late transitionstate analogue
BnT-DADMe-ImmA, the Ki value is substantially higher for Bgp (2.3 nM) and Pfs (3.4 nM) than that reported for E. coli
nucleosidase (28 pM),29 although it is similar to that reported for the Streptococcus pneumoniae enzyme (5 nM).20
High-throughput screening of different inhibitors of MTA/SAH nucleosidase on the growth of B. burgdorferi.
Based upon the kinetic analysis with purified recombinant Bgp and Pfs of B. burgdorferi (Figure 3), we assessed the
inhibitory activities of all four compounds against the infectious spirochaete strain N40. The Hoechst/Sytox Green stain
mixture was used to evaluate total and physiologically compromised B. burgdorferi, respectively. Calculation of the net
Sytox Green fluorescence values (Sytox Green/Hoechst) after treatment with the inhibitors was followed by the
determination of the bacteriostatic/dead bacteria present in the samples using the standard in Figure 1(c) to evaluate the
inhibitory activities of these compounds. The results obtained with pNH2PhTA and BnT-DADMe ImmA indicate that even
at a relatively high concentration (10 µM), these inhibitors only partially affected the physiological status of the spirochaetes
(Figure 4). However, the fluorometric assay suggested that both pNO2PhTA and FMA are highly effective inhibitors against
B. burgdorferi. The MIC of these two inhibitors is lower than the least concentration tested here (0.016 µM) as detected by
fluorometric analysis (Figure 4).
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Figure 3. Summary of inhibition constants for MTA analogues compared with Km values for native
MTA and SAH substrates for Bgp and Pfs enzymes. Enzyme assays were conducted using UV
spectrophotometry (275 nm) and pH conditions optimized for Bgp (pH 7) and Pfs (pH 5). For MTA and
SAH, concentrations from 1 to 100 µM were evaluated. Inhibitor effects were determined using varying
concentrations of inhibitor and a fixed concentration of MTA (100 µM). Inhibition constants were
determined by fitting the initial rates of the inhibited (Vo’) and uninhibited (Vo) reactions to the equation
for competitive inhibition: Vo’/Vo = (Km + [S])/{(Km + [S] + Km[I]/Ki)}.29 Inhibitor effects appear to
be similar for each of the enzymes, with the strongest inhibition exhibited by the non-hydrolysable late
transition-state analogue BnT-DADMe-ImmA (Ki=2.3 and 3.4 nM for BGP and Pfs, respectively).
The effectiveness of this fluorometric assay system and potency of these inhibitors were further confirmed by microscopic
examination of the samples. Indeed, microscopic examination after treatment confirmed the presence of dead or dying
spirochaetes, as stained by Sytox Green (Figure 5). The staining was not as intense and uniform for the spirochaetes as
observed by Sytox Green staining of the heat-killed spirochetes (Figure 2). However, fewer spirochaetes treated with
pNH2PhTA and BnT-DADMe-ImmA (average of 43.8+4.0% and 45.1+3.1%, respectively, from 10 different fields) were
visualized by Sytox Green staining when compared with those detected by Hoechst staining or DIC microscopy, while most
spirochaetes stained with Sytox Green (average of 68.6+4.2% from 10 fields) after treatment with pNO2PhTA,
complementing our results from fluorometric analysis. Exclusion of Sytox Green by several spirochaetes after FMA
treatment (only an average of 51.3+5.5% stained with Sytox Green) was surprising. Hence, pNO2PhTA appears to be most
effective against B. burgdorferi also by microscopic examination.
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MTA/SAH substrate analogues show
either bacteriostatic or bactericidal
activities against infectious B.
burgdorferi N40 strain. To examine
whether the inhibitory activities of the
four substrate analogues against
spirochaetes have bactericidal or
bacteriostatic effects, we recovered
small aliquots (2 µL) from the treated
samples daily and cultured B.
burgdorferi in BSK II medium
containing 6% rabbit serum without
inhibitors. After treatment with all four
compounds up to 4 days, at least some
spirochaetes
survived even after exposure to 10 µM
(data not shown). However, we were
Figure 4. Treatment of B. burgdorferi with MTA/SAH nucleosidase
unable to recover live spirochaetes
inhibitors affects their membrane permeability. Fluorometric analysis
when the N40 strain was treated with a
of B. burgdorferi after treatment with four inhibitors overnight
higher concentration of FMA for 7
followed by staining with a Hoechst/Sytox Green mixture was
days. The recovery of spirochaetes was
conducted as described in the legend to Figure 1. Both pNO2PhTA and
also poor after treatment with
FMA affected the physiological state of the spirochaetes significantly,
pNH2PhTA. Such a subtle distinction
as indicated by membrane permeability to Sytox Green, even at a
between the three inhibitors was not
concentration of 0.016 mM, while pNH2PhTA and BnT-DADMepossible with the fluorometric analysis.
In these studies, FMA appears to be
ImmA showed much weaker antibacterial effects.
bactericidal against B. burgdorferi after
prolonged treatment while the other three MTA nucleosidase inhibitors could be bacteriostatic under the tested
concentrations.
Modeling studies of Bgp and Pfs with FMA.
The availability of a crystal structure of the E. coli MTA/SAH nucleosidase33 with FMA bound in the active site allowed
preliminary predictions of the three-dimensional features of Bgp and Pfs to be made using modeling programs (Figure 6a).
Ribbon threading of the B. burgdorferi Pfs (in blue) onto the known E. coli enzyme structure (in yellow) predicts very similar
structures without additional energy minimizations. Threading the Bgp enzyme (in pink) onto the E. coli enzyme also
predicted highly similar structures, although a less organized loop structure was suggested in the model to replace regions of
alpha helices found in Pfs. Surface charges and the orientation of the 5’-hydroxyl group (O5 in Figure 6b) facing out of the
active site pocket supports the availability of the 5’ position of the nucleoside for modification. From the model, the purinebinding pocket is predicted to be more restricted in Pfs than Bgp.
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Active site residues involved in catalysis (E12, E174 and D197) are strictly conserved in Bgp (E34, E209 and D232) and Pfs
(E11, E181 and D204). As expected, the highly homologous cytoplasmic E. coli nucleosidase and Pfs are suggested to have
essentially the same secondary and tertiary structure in the model. Of note, the Bgp backbone is predicted to loop away from

Figure 5. Microscopic examination of B. burgdorferi confirmed the adverse effects of MTA/SAH inhibitors on
the physiological status of the spirochaetes. Almost all spirochaetes showed green fluorescence due to staining
with Sytox Green after treatment with pNO2PhTA, while several B. burgdorferi excluded this stain after
NH2PhTA and BnT-DADMe-ImmA treatment for 7 days (as marked by arrows), hence confirming our results
with fluorometric analysis. Exclusion of Sytox Green by some B. burgdorferi after FMA treatment was
unexpected. The presence of vesicular, cyst-like structures observed after each treatment indicated the damaging
effect of all four inhibitors on the Lyme spirochaetes.

the other two strands at a juncture between β8 and α4 (yellow arrow in front view) in a region that provides a face for the
purine-binding site. As shown in Figure 6(b), modeling of the electrostatic surface charges suggests that this divergence has
the effect of orienting the phenyl ring of F187 in Bgp outward from the active site. By comparison, F158 of Pfs (F151 in E.
coli) shields the active site and forms stabilizing aromatic interactions with the adenine ring of the substrate.13,20 Other small
changes in the identity and position of residues around the entrance to the active site of Bgp are suggested as well in Figure
6(b). A replacement of Pfs F215 (E. coli F207) with slightly rotated Y243 in Bgp would predict a decrease in apparent
shielding of N7 of the purine ring, while a substitution of Pfs I53 (I50 in E. coli) with V79 in Bgp suggests an increase in the
accessibility of the bottom of the pocket.
Discussion
Limiting factors for the treatment of patients to curtail certain bacterial diseases are the incessant emergence of antibiotic
resistance among various pathogens and intolerance of some patients against certain antibiotics.2,34 These often lead to the
employment of a combination regimen of drugs for treatment. Alternatively, relatively less effective drugs are included in the
treatment of drug-intolerant patients. Therefore, there is an urgent need to explore novel physiological inhibitors as the
potential antimicrobials against bacterial pathogens, including B. burgdorferi. Success of the enzymatic inhibitors as
antimicrobials depends on: (i) their ability to selectively restrict the growth of the pathogens without interfering with the
human enzymes; and (ii) their broad effectiveness against various pathogens. In this study, we have examined substrate
analogues of MTA/SAH nucleosidase enzymes of B. burgdorferi as potential antimicrobials.

K. A. Cornell, S. Primus, J. A. Martinez & N. Parveen in JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

10

This is a pre-copy-editing, author-produced PDF of an article accepted for publication in the Journal of Antimicrobial Chemotherapy following peer
review. The definitive publisher-authenticated version Journal of Antimicrobial Chemotherapy 2009 63(6):1163-1172 is available online at:
doi:10.1093/jac/dkp129

Two activities of nucleosidase, cleavage of MTA and SAH, are carried out by two different enzymes in mammals, MTA
phosphorylase and SAH hydrolase.35 While mammalian SAH hydrolase and bacterial MTA/SAH nucleosidase are not
structurally similar, the crystal structures of the mammalian MTA phosphorylase enzyme and MTA/SAH nucleosidase of E.
coli show significant similarities. A comparison of their active sites shows remarkable similarities in the residues involved in
adenine binding, although the pocket enclosing N5 appears to be more open in the mammalian enzyme.13 Significant
structural differences exist in the ribose-binding site between the two enzymes, where

Figure 6. Superimposed ribbon structures of MTA/SAH nucleosidases and close-up of surface electrostatic
maps of Bgp and Pfs enzyme active sites containing FMA. (a) The sequences of Bgp (pink) and Pfs (blue)
were threaded onto the known three-dimensional structure of E. coli MTA/SAH nucleosidase monomer (PDB
1nc3A) (yellow) using SWISS-Model. A ball and stick structure of docked FMA is shown (blue=nitrogen;
red=oxygen).
Overall, the structures of Bgp and Pfs appear to be highly conserved with the E. coli enzyme. (b) In the closeup of the surface structural map of the MTA/SAH nucleosidases, charges are represented in red (negative) and
blue (positive). The orientation of the 5’-hydroxyl group (O5 in the figure) facing out of the active site pocket
supports the availability of the 5’ position of the nucleoside for modification. From the model, the purinebinding pocket is suggested to be more restricted in Pfs than Bgp.

phosphate-binding amino acid residues in MTA phosphorylase, Arg and Thr, are replaced by Ser and Gly in the bacterial
nucleosidase, hence preventing the charge–charge interactions.13,14 Importantly, the channel containing the 5’-alkylthio group
of the MTA/SAH nucleosidase appears more open than in the mammalian enzyme, thus providing an explanation for the dual
substrate specificity of the bacterial enzyme. Interactions between residues from the second chain of the nucleosidase dimer
and the extended 5’-alkylthio group of SAH may provide additional stabilization and recognition.15
The models of B. burgdorferi proteins, while suggestive, should not be overinterpreted in the absence of true crystallographic
evidence. The differences seen between the Km values for MTA between Bgp (5 mM) and Pfs (0.7 mM) may be explained by
the small structural differences suggested in the models. These activity differences could also represent differences in the
behaviours of the recombinant enzymes and conditions under which the assays were conducted. Prior evidence24 supported a
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lower Bgp Km for MTA (1.2 µM), which was more in line with the submicromolar values found for Pfs and the E. coli
nucleosidase, but that assay followed the conversion of radioactive MTA into MTR, rather than direct spectrophotometric
observance of substrate conversion that is reported here. In either case, the Km values reported here for both enzymes for
MTA and SAH are similar to the values in the literature for the E. coli and Klebsiella nucleosidases28,36,37 and roughly an
order of magnitude lower than those recently reported for S. pneumoniae nucleosidase.20
Taking advantage of the suggested structural similarities of MTA/SAH nucleosidases, we first conducted kinetic analysis of
four previously examined inhibitors,13,15,36,38,39 with the purified recombinant Bgp and Pfs proteins followed by their
evaluation with intact B. burgdorferi. Fluorometric analysis of the effect of MTA/SAH nucleosidase inhibitors on B.
burgdorferi facilitated the identification of pNO2PhTA and FMA as more effective compounds against the spirochaetes.
Interestingly, the IC50 of these inhibitors in damaging the plasma membrane integrity is much lower than that reported for the
purified E. coli enzyme previously36,40 as well as shown here (Figure 3) for purified B. burgdorferi nucleosidases. These
results suggest that MTA/SAH nucleosidase could be an even better target of the substrate analogues as antimicrobials in B.
burgdorferi than other bacterial pathogens. This is likely due to the additive effect of these inhibitors on all three spirochaete
enzymes in the intact organisms. In addition, B. burgdorferi may be more permeable to these inhibitors when compared with
Gram-negative bacteria since their outer membrane lacks lipopolysaccharide and is more flexible. FMA showed a significant
bactericidal activity against B. burgdorferi after prolonged treatment. Interestingly, pNH2PhTA, and not pNO2PhTA, seems
to result in a significant level of killing of the spirochaetes at high dose (10 µM) on prolonged treatment, as detected by
cultivation in the absence of an inhibitor. Such a subtle distinction between the inhibitors’ activities was not possible with the
fluorometric, and even microscopic, analysis. In a human bone marrow cell growth assay, both pNH2PhTA and pNO2PhTA
showed low toxicity, with IC50 values >100 µM (K.A.C., unpublished data), suggesting that their toxicity to B. burgdorferi is
selective.
In summary, we have developed a novel high-throughput, fluorometric screening method for B. burgdorferi viability after
treatment with the potential antimicrobials, and have assessed its effectiveness using MTA/SAH nucleosidase as a target.
After characterization of the inhibitors in our collection using purified recombinant B. burgdorferi nucleosidase, we further
used this fluorometric method, as well as analysis by microscopy and culture to assess the potency of these inhibitors as
antimicrobials. We report here that pNO2PhTA and FMA have high inhibitory activities on B. burgdorferi even at very low
concentrations (0.016 µM). In addition, FMA is potentially bactericidal when treatment is extended to 7 days. These results
indicate that the MTA/SAH nucleosidase enzyme is an excellent target for the discovery of new antimicrobials against Lyme
disease spirochaetes. This study further supports potential use of novel inhibitors against this critically important enzyme for
the treatment of Lyme disease in the future, especially when patients are intolerant to doxycycline, amoxicillin or cefuroxime
axetil, for pregnant women or potentially for patients suffering from chronic Lyme disease. We will examine other substrate
analogues for this enzyme as well as attempt chemical modification of already effective inhibitors based upon the structure
and residues of the substrate-binding site of the enzymes to further enhance their bactericidal activity against Lyme disease
spirochaetes in the future.
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